Literature DB >> 15722660

Nonarteritic anterior ischemic optic neuropathy.

Niraj Desai1, Milan R Patel, L Michael Prisant, Dilip A Thomas.   

Abstract

Nonarteritic anterior ischemic optic neuropathy is a common cause of sudden, painless loss of vision present commonly on awakening from sleep. It most commonly affects middle-aged and elderly Caucasian men and women. Involvement of the opposite eye occurs within 3 years in less than 43% of patients. Hypertension, diabetes, and nocturnal hypotension are risk factors. A congenital small cup-to-disk ratio also predisposes to the optic nerve ischemia. There is no effective therapy to treat patients acutely or to prevent recurrence. After 6 months of careful follow-up, 57.3% of patients will have no significant change or worsening of their vision in the involved eye.

Entities:  

Mesh:

Year:  2005        PMID: 15722660      PMCID: PMC8109556          DOI: 10.1111/j.1524-6175.2005.04095.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  23 in total

Review 1.  Nonarteritic anterior ischemic optic neuropathy.

Authors:  Lawrence M Buono; Rod Foroozan; Robert C Sergott; Peter J Savino
Journal:  Curr Opin Ophthalmol       Date:  2002-12       Impact factor: 3.761

2.  Characteristics of patients with nonarteritic anterior ischemic optic neuropathy eligible for the Ischemic Optic Neuropathy Decompression Trial.

Authors: 
Journal:  Arch Ophthalmol       Date:  1996-11

3.  Role of axoplasmic transport in the pathophysiology of ischaemic disc swelling.

Authors:  D McLeod; J Marshall; E M Kohner
Journal:  Br J Ophthalmol       Date:  1980-04       Impact factor: 4.638

Review 4.  Role of nocturnal arterial hypotension in the development of ocular manifestations of systemic arterial hypertension.

Authors:  S S Hayreh
Journal:  Curr Opin Ophthalmol       Date:  1999-12       Impact factor: 3.761

5.  Hypertension and chronotherapy: shifting the treatment paradigm.

Authors:  L M Prisant
Journal:  Am J Hypertens       Date:  2001-09       Impact factor: 2.689

6.  Beta-blocker eyedrops and nocturnal arterial hypotension.

Authors:  S S Hayreh; P Podhajsky; M B Zimmerman
Journal:  Am J Ophthalmol       Date:  1999-09       Impact factor: 5.258

7.  The fellow eye in NAION: report from the ischemic optic neuropathy decompression trial follow-up study.

Authors:  Nancy J Newman; Roberta Scherer; Patricia Langenberg; Shalom Kelman; Steven Feldon; David Kaufman; Kay Dickersin
Journal:  Am J Ophthalmol       Date:  2002-09       Impact factor: 5.258

8.  Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders.

Authors:  S S Hayreh; M B Zimmerman; P Podhajsky; W L Alward
Journal:  Am J Ophthalmol       Date:  1994-05-15       Impact factor: 5.258

9.  Anterior ischemic optic neuropathy. IX. Cup-to-disc ratio and its role in pathogenesis.

Authors:  R W Beck; G E Servais; S S Hayreh
Journal:  Ophthalmology       Date:  1987-11       Impact factor: 12.079

10.  Systemic diseases associated with nonarteritic anterior ischemic optic neuropathy.

Authors:  S S Hayreh; K M Joos; P A Podhajsky; C R Long
Journal:  Am J Ophthalmol       Date:  1994-12-15       Impact factor: 5.258

View more
  2 in total

1.  Non-arteritic anterior ischaemic optic neuropathy secondary to menorrhagia in a young healthy woman.

Authors:  Koon-Ling Koh; Khairy Shamel Sonny Teo; Mei-Fong Chong; Wan-Hazabbah Wan Hitam
Journal:  BMJ Case Rep       Date:  2018-06-27

2.  The Efficacy of Glucocorticoids in the Treatment of Nonarteritic Anterior Ischemic Optic Neuropathy: A Systematic Review and Meta-Analysis.

Authors:  Pingping Zhou; Jian Zhang; Yanxiu Qi
Journal:  Comput Math Methods Med       Date:  2022-03-18       Impact factor: 2.238

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.